FIELD: medicine.
SUBSTANCE: invention can be used for treating asthma by normalizing a score according to a questionnaire for assessing asthma in a patient. That is ensured by subcutaneous injection of benralizumab or its antigen-binding fragment 30 mg once every four weeks for twelve weeks. Then once in eight weeks. Patient's eosinophil count is at least 300 cells/mql. Questionnaire for assessing asthma is selected from a group consisting of an asthma control questionnaire (ACQ), an asthma control questionnaire (ACQ-6) and a questionnaire for assessing the quality of life in asthmatic patients (AQLQ).
EFFECT: invention provides normalizing a score according to a questionnaire for assessing asthma in a patient with asthma.
11 cl, 4 tbl, 10 dwg, 3 ex
| Title |
Year |
Author |
Number |
| METHODS OF TREATMENT OR PREVENTION OF ASTHMA THROUGH ADMINISTRATION OF IL-4R ANTAGONIST |
2013 |
- Ardeleanu, Marius
- Gandhi, Namita
- Graham, Neil
- Kirkesseli, Stephane, C.
- Kundu, Sudeep
- Radin, Allen
- Rocklin, Ross, E.
- Weinstein, Steven
- Davidson Hamilton, Jennifer
- Ming, Jeffrey
|
RU2801531C2 |
| TREATMENT AND INHIBITION OF INFLAMMATORY LUNG DISEASES IN PATIENTS WITH RISK ALLELES IN GENES ENCODING IL33 AND IL1RL1 |
2018 |
- Bruse, Shannon
- Mccarthy, Shane
- Baras, Aris
- Dewey, Frederick
- Gottesman, Omri
|
RU2776241C2 |
| ANTIBODY AGAINST IL-5, ITS ANTIGEN-BINDING FRAGMENT AND ITS MEDICAL USE |
2018 |
- In, Khua
- Shi, Tszinpin
- Van, Ifan
- Khu, Tsiyue
- Ge, Khu
- Tao, Vejkan
|
RU2772716C2 |
| HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING SPECIFIC GROUPS OF INDIVIDUALS |
2012 |
- Hanotin, Corinne
- Bessac, Laurence
- Chaudhari, Umesh
|
RU2721279C2 |
| COMBINATION |
2015 |
- Lyne, Paul, Dermot
- Mccoon, Patricia, Elizabeth
- Woessner, Richard
|
RU2744841C2 |
| DOSING STRATEGY REDUCING CYTOKINE RELEASE SYNDROME FOR CD3/C20 BISPECIFIC ANTIBODIES |
2019 |
- Brownstein, Carrie
- Lowy, Israel
- Adriaens, Lieve Lucille
|
RU2799529C2 |
| ANTIBODY AGAINST HUMAN INTERLEUKIN-4 ALPHA RECEPTOR, METHOD OF ITS PREPARATION AND ITS APPLICATION |
2021 |
- Zhang, Chenghai
- Guo, Jinlin
- Yuan, Yujing
|
RU2807060C1 |
| PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTING AND/OR TREATING A DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF REDUCING OR LOSING ACTIVITY OF THE BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED COAGULATION FACTOR VIII |
2015 |
|
RU2721910C2 |
| METHODS FOR TREATMENT OF HYPERLIPIDEMIA IN PATIENTS WITH DIABETES BY INJECTION OF PCSK9 INHIBITOR |
2018 |
|
RU2772712C2 |
| ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE |
2019 |
- Beaumont, Kevin Charles
- Breen, Danna M.
- Chabot, Jeffrey Raymond
- He, Tao
- Shchors, Ksenya
- Apgar, James R.
- Lambert, Matthew Allister
|
RU2795457C2 |
